CarrTech Archives · BioBuzz

Loading …

In Conversation: Sue Carr, Founder and President of CarrTech, LLC

<img width="300" height="300" alt="" data-srcset="https://biobuzz.io/wp-content/uploads/2021/03/CarrTech-The-FROG-300x300.png 300w, https://biobuzz.io/wp-content/uploads/2021/03/CarrTech-The-FROG-150x150.png 150w, https://biobuzz.io/wp-content/uploads/2021/03/CarrTech-The-FROG-75x75.png 75w" data-src="https://biobuzz.io/wp-content/uploads/2021/03/CarrTech-The-FROG-300x300.png" data-sizes="(max-width: 300px) 100vw, 300px" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image lazyload lazyload" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" /><noscript><img width="300" height="300" src="https://biobuzz.io/wp-content/uploads/2021/03/CarrTech-The-FROG-300x300.png" class="attachment-biobuzz-medium size-biobuzz-medium wp-post-image lazyload" alt="" srcset="https://biobuzz.io/wp-content/uploads/2021/03/CarrTech-The-FROG-300x300.png 300w, https://biobuzz.io/wp-content/uploads/2021/03/CarrTech-The-FROG-150x150.png 150w, https://biobuzz.io/wp-content/uploads/2021/03/CarrTech-The-FROG-75x75.png 75w" sizes="(max-width: 300px) 100vw, 300px" />

Published on : March 2, 2021March 2, 2021 Published by : Steven Surdez

The traditional two-needle approach to filtering injectable glass ampoule-based medications is unsafe to health care providers and patients. The process is also time-consuming and costly.